Distinct Filament Conformation for Receptor-Bound Amyloid-ß from Alzheimer's Disease Brain
Mikhail A Kostylev1, Carmen Butan1, Graham P Roseman1
1Departments of Neuroscience and Neurology, Yale School of Medicine, 100 College Street, New Haven, CT 06510, USA.
Biorxiv : the Preprint Server for Biology
|November 24, 2025
Summary
Alzheimer's disease involves amyloid-ß (Aß) triggering synapse loss. Researchers identified a distinct, receptor-bound Aß filament in the brain, crucial for prion protein interaction and synaptic damage, offering new insights beyond plaque aggregation.
Area of Science:
- Neuroscience
- Biochemistry
- Molecular Biology
Background:
- Alzheimer's disease (AD) pathogenesis is linked to amyloid-ß (Aß) and synapse loss.
- Oligomeric Aß is suspected as the cause, but its molecular details remain elusive.
- Existing research often overlooks receptor-bound Aß species.
Purpose of the Study:
- To define the molecular characteristics of receptor-bound Aß in Alzheimer's disease brains.
- To investigate the role of receptor-bound Aß in synaptic dysfunction and prion protein interaction.
- To differentiate receptor-bound Aß from plaque-associated Aß filaments.
Main Methods:
- Isolation and purification of receptor-bound Aß using a receptor antagonist.
- Cryo-electron microscopy (Cryo-EM) for structural determination.
- Analysis of prion protein binding and synaptic damage potential.
Main Results:
- A distinct pool of receptor-bound Aß filaments (65 nm) was identified, 10x more abundant than free Aß.
- These filaments feature prion protein binding at their tips and consist of S-shaped monomers.
- Structural analysis revealed unique features distinguishing them from plaque-associated Aß.
- No evidence of oligomeric Aß interacting with human brain receptors was found.
Conclusions:
- Receptor-bound Aß filaments, not oligomers, are critical for prion protein interaction and synaptic damage in AD.
- The high tip:length ratio of these filaments is key to their neurotoxic mechanism.
- Understanding receptor-bound Aß offers insights into neuronal dysfunction distinct from plaque pathology.
Related Concept Videos
Amyloid Fibrils
11.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
11.5K
Amyloid Fibrils
6.3K
6.3K


